N-Ethylnorketamine

HOW TO PURCHASE N-ETHYLNORKETAMINE ONLINE IN AUSTRALIA

N-Ethylnorketamine, a member of the Arylcyclohexylamine family, has garnered attention in Australia for its intriguing chemical properties. This compound shares structural similarities with well-known substances like 2-MeO-Ketamine and Ketamine. It is commonly referred to by several names, including Ethketamine, ethyl ketamine, and N-ethyldesmethyl ketamine, highlighting its diverse applications and recognition in various contexts.

EFFECTS OF N-ETHYLNORKETAMINE IN AUSTRALIA

N-Ethylnorketamine exhibits effects analogous to those of Ketamine in Australia, known for inducing hallucinogenic and sedative experiences. Users often report similarities in the overall experience between these two substances, resulting in a unique blend of effects that can alter perception and consciousness.

WHERE TO BUY N-ETHYLNORKETAMINE IN AUSTRALIA?

If you are looking to buy N-Ethylnorketamine, it is available online through platforms such as Zonez Pharma in Australia. This particular vendor allows you to purchase  conveniently without the need for a prescription, offering competitive prices and the promise of delivery right to your doorstep within a specified timeframe.

N-Ethylnorketamine is classified as an empirical reference resource within the realm of amphetamines, though its biochemical and toxicological properties remain largely uncharted territory. The effects are anticipated to mirror those of its predecessor, ketamine, and have found popularity among recreational users seeking dissociative experiences. Initially marketed online since September 2012, this substance’s presence has been noted in testing labs across the Australia and other European nations, often discovered during the confiscation of prescription samples.

As a member of the Arylcyclohexylamine family, N-Ethylnorketamine functions as a dissociative drug in Australia. Research suggests that the addition of the N-ethyl group modifies its properties, potentially leading to effects that closely resemble those of ketamine, albeit with an extended duration and enhanced potency. This alteration has attracted individuals who are already familiar with ketamine’s effects, particularly those interested in longer-lasting experiences.

ANESTHETIC AND ANALGESIC PROPERTIES 

N-Ethylnorketamine possesses notable anesthetic and analgesic qualities but presents a risk of abuse, similar to many substances within the growing class of arylcyclohexylamines—comprising a myriad of new psychoactive substances, including various ketamine analogs in Australia. Preliminary studies investigating its pharmacological profile indicate significant findings.

In controlled experiments, the ED50 values, which denote the effective dose required to achieve 50% of the desired therapeutic effect, were determined to be 96.9 mg/kg for anesthetic activity and 45.9 mg/kg for analgesic activity regarding N-Ethylnorketamine. In contrast, Ketamine showed lower ED50 values of 69.4 mg/kg and 23.6 mg/kg for the same activities, respectively.

Further examination revealed that N-Ethylnorketamine induces a notable conditioned place preference in test subjects at a minimum dosage of 10.0 mg/kg in Australia, a response that parallels the effects observed with Ketamine at a reduced dose of 3.0 mg/kg. Moreover, when administered at a dosage of 30.0 mg/kg, both N-Ethylnor and Ketamine were found to enhance locomotor activity. Repeated exposure to this dosage subsequently led to locomotor sensitization post-withdrawal.

Overall, the results from these studies point to a compelling narrative: while N-Ethylnor may exhibit lower anesthetic and analgesic efficacy compared to Ketamine, it carries a significant potential for abuse, raising critical questions about its safety and regulation in both therapeutic and recreational contexts.